{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:47:03Z","timestamp":1786985223694,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["253814"],"award-info":[{"award-number":["253814"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.biopha.2018.09.074","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T22:08:40Z","timestamp":1537481320000},"page":"670-678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Design, synthesis, in vitro, in vivo and in silico pharmacological characterization of antidiabetic N-Boc-l-tyrosine-based compounds"],"prefix":"10.1016","volume":"108","author":[{"given":"Miguel \u00c1ngel","family":"Herrera-Rueda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Tlahuext","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6448-7266","authenticated-orcid":false,"given":"Paolo","family":"Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1076-6731","authenticated-orcid":false,"given":"Abraham","family":"Giacoman-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9417-5500","authenticated-orcid":false,"given":"Julio C\u00e9sar","family":"Almanza-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"P\u00e9rez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Guti\u00e9rrez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Ch\u00e1vez-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elix Alberto","family":"Dominguez-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Estrada-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5344-4762","authenticated-orcid":false,"given":"Gabriel","family":"Navarrete-Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.09.074_bib0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejmech.2018.03.041","article-title":"Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus","volume":"151","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.074_bib0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/molecules23020340","article-title":"Design, synthesis and in combo antidiabetic bioevaluation of multitarget phenylpropanoic acids","volume":"23","author":"Col\u00edn-Lozano","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2018.09.074_bib0015","first-page":"150","article-title":"Dyslipidemia in type 2 diabetes mellitus","volume":"5","author":"Mooradian","year":"2009","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2018.09.074_bib0020","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.jdiacomp.2016.07.011","article-title":"Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients","volume":"30","author":"de Souza Bastos","year":"2016","journal-title":"J. Diab. Complications"},{"key":"10.1016\/j.biopha.2018.09.074_bib0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00399961","article-title":"Diabetes mellitus and hypertension: the possible role of hyperglycemia through oxidative stress","volume":"36","author":"Ceriello","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2018.09.074_bib0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2016.08.324","article-title":"Metabolic syndrome and its individual components with mortality among patients with coronary heart disease","volume":"224","author":"Chen","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2018.09.074_bib0035","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1016\/j.bmcl.2014.07.068","article-title":"Synthesis, in vitro and in silico studies of a PPAR\u03b3 and GLUT-4 modulator with hypoglycemic effect","volume":"24","author":"Navarrete-V\u00e1zquez","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2018.09.074_bib0040","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/MCB.26.9.3455-3467.2006","article-title":"FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity","volume":"26","author":"Wu","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2018.09.074_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.phrs.2007.03.002","article-title":"PPAR dual agonists: are they opening pandora\u2019s box?","volume":"56","author":"Balakumar","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2018.09.074_bib0050","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1021\/ml300427u","article-title":"Discovery and optimization of potent GPR40 full agonists containing tricyclic spirocycles","volume":"4","author":"Wang","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2018.09.074_bib0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4103\/2231-4040.165013","article-title":"Hydroalcoholic seed extract increases glucose consumption in 3T3-L1 adipocytes through activation of peroxisome proliferator-activated receptor gamma and insulin sensitization","volume":"6","author":"Parimala","year":"2015","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.biopha.2018.09.074_bib0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3164\/jcbn.16-120","article-title":"Oleuropein improves insulin resistance in skeletal muscle by promoting the translocation of GLUT4","volume":"61","author":"Fujiwara","year":"2017","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.biopha.2018.09.074_bib0065","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.bbalip.2007.05.005","article-title":"The next generation of PPAR drugs: do we have the tools to find them?","volume":"1771","author":"Shearer","year":"2007","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.biopha.2018.09.074_bib0070","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1021\/jm030631e","article-title":"Peroxisome proliferator-activated receptor Alpha\/gamma dual agonists for the treatment of type 2 diabetes","volume":"47","author":"Henke","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.074_bib0075","doi-asserted-by":"crossref","first-page":"546548","DOI":"10.1155\/2012\/546548","article-title":"in vitro and in vivo characterizations of chiglitazar, a newly identified PPAR pan-agonist","volume":"2012","author":"He","year":"2012","journal-title":"PPAR Res."},{"key":"10.1016\/j.biopha.2018.09.074_bib0080","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bbalip.2007.02.003","article-title":"Safety issues and prospects for future generations of PPAR modulators","volume":"1771","author":"Rubenstrunk","year":"2007","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.biopha.2018.09.074_bib0085","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.bmc.2009.03.042","article-title":"Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity","volume":"17","author":"Navarrete-Vazquez","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.074_bib0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejmech.2012.04.025","article-title":"Synthesis, in vitro and in silico screening of ethyl 2-(6-substituted benzo[d]thiazol-2-ylamino)-2-oxoacetates as protein-tyrosine phosphatase 1B inhibitors","volume":"53","author":"Navarrete-Vazquez","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.074_bib0095","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.bmcl.2016.02.082","article-title":"In vitro and in silico PTP-1B inhibition and in vivo antidiabetic activity of semisynthetic moronic acid derivatives","volume":"26","author":"Cer\u00f3n-Romero","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2018.09.074_bib0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2013.12.042","article-title":"Synthesis of 2-{2-[(\u03b1\/\u03b2-naphthalen-1-ylsulfonyl)amino]-1,3-thiazol-4-yl}acetamides with 11\u03b2-hydroxysteroid dehydrogenase inhibition and in combo antidiabetic activities","volume":"74","author":"Navarrete-V\u00e1zquez","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.074_bib0105","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ejmech.2014.10.083","article-title":"Structural development studies of PPARs ligands based on tyrosine scaffold","volume":"89","author":"Filippis","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.074_bib0110","first-page":"1","article-title":"Targeting peroxisome proliferator-activated receptors using thiazolidinediones: strategy for design of novel antidiabetic drugs","volume":"2017","author":"Thangavel","year":"2017","journal-title":"Int. J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.074_bib0115","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1016\/j.bmcl.2010.08.130","article-title":"Novel thiazolidinedione derivatives with anti-obesity effects: dual action as PTP-1B inhibitors and PPAR-\u03b3 activators","volume":"20","author":"Bhattarai","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2018.09.074_bib0120","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bbagen.2006.12.012","article-title":"Site-directed mutagenesis of two aromatic residues lining the active site pocket of the yeast Ltp1","volume":"1770","author":"Paoli","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2018.09.074_bib0125","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/cbdd.12102","article-title":"Discovery of thiazolidine-2,4-dione\/biphenylcarbonitrile hybrid as dual PPAR \u03b1\/\u03b3 modulator with antidiabetic effect: in vitro, in silico and in vivo approaches","volume":"81","author":"Hidalgo-Figueroa","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biopha.2018.09.074_bib0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ejphar.2008.03.051","article-title":"Glycine increases mRNA adiponectin and diminishes pro-inflammatory adipokines expression in 3T3-L1 cells","volume":"587","author":"Garc\u00eda-Macedo","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.09.074_bib0135","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.biopha.2009.04.047","article-title":"Glycine regulates inflammatory markers modifying the energetic balance through PPAR and UCP-2","volume":"64","author":"Almanza-P\u00e9rez","year":"2010","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.09.074_bib0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.biopha.2017.03.033","article-title":"Discovery of new dual PPAR\u03b3-GPR40 agonists with robust antidiabetic activity: design, synthesis and in combo drug evaluation","volume":"90","author":"Hidalgo-Figueroa","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.09.074_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/1212609","article-title":"Synthesis and in vitro AMPK activation of cycloalkyl\/alkarylbiguanides with robust in vivo antihyperglycemic action","volume":"1212609","author":"Gutierrez-Lara","year":"2017","journal-title":"J. Chem."},{"key":"10.1016\/j.biopha.2018.09.074_bib0150","series-title":"Molecular Operating Environment (MOE), 2018.01","year":"2018"},{"key":"10.1016\/j.biopha.2018.09.074_bib0155","series-title":"Drug Selectivity. An Evolving Concept in Medicinal Chemistry","first-page":"1","article-title":"Polypharmacology in drug Discovery","author":"M\u00e9ndez-Lucio","year":"2017"},{"key":"10.1016\/j.biopha.2018.09.074_bib0160","unstructured":"http:\/\/bio-hpc.ucam.edu\/dia-db\/."},{"key":"10.1016\/j.biopha.2018.09.074_bib0165","first-page":"655","article-title":"DIA-DB: a web-accessible database for the prediction of diabetes drugs","volume":"9044","author":"S\u00e1nchez-P\u00e9rez","year":"2015","journal-title":"Bioinform. Biomed. Eng."},{"key":"10.1016\/j.biopha.2018.09.074_bib0170","doi-asserted-by":"crossref","first-page":"34792","DOI":"10.1038\/srep34792","article-title":"Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode","volume":"6","author":"Capelli","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.09.074_bib0175","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.biopha.2018.08.124","article-title":"Synthesis and evaluation of thiazolidine-2,4-dione\/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): antihyperglycemic activity with molecular docking study","volume":"107","author":"Hidalgo-Figueroa","year":"2018","journal-title":"Biomed. Pharmacother."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218338381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218338381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:31:38Z","timestamp":1777271498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218338381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":35,"alternative-id":["S0753332218338381"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.074","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, in vitro, in vivo and in silico pharmacological characterization of antidiabetic N-Boc-l-tyrosine-based compounds","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}